Research Updates: Effectiveness of a new home-based pregnanediol glucuronide (PDG) urine test to confirm ovulation
9th February 2021 @ 8:00 PM - 9:00 PM GMT
Grand rounds is held monthly for health care professionals as part of RRM's Educational Webinar Series. Presentations aim to improve the clinician's foundational knowledge as well as highlight and encourage research and new methods in the area of Restorative Reproductive Medicine. These sessions should enhance the efficiency, effectiveness and quality of healthcare delivery, and in turn lead to improved patient outcomes.
This session is approved for 1.0 Prescribed credit by the American Academy of Family Physicians (AAFP)*. For more information about how how this can be reported and submitted to other organizations please see the AAFP website here.
Webinars are free for all IIRRM members.
Not a member? Join or renew your membership here.
1. Leiva, Rene & McNamara-Kilian, Marie & Niezgoda, Helen & Ecochard, Rene & Bouchard, Thomas. (2019). Pilot observational prospective cohort study on the use of a novel home-based urinary pregnanediol 3-glucuronide (PDG) test to confirm ovulation when used as adjunct to fertility awareness methods (FAMs) stage 1. BMJ Open. 9. e028496. 10.1136/bmjopen-2018- 028496.
2. Leiva RA, Bouchard TP, Abdullah SH, Ecochard R. Urinary Luteinizing Hormone Tests: Which Concentration Threshold Best Predicts Ovulation? [published correction appears in Front Public Health. 2018 Nov 30;6:345]. Front Public Health. 2017;5:320. Published 2017 Nov 28. doi:10.3389/fpubh.2017.00320
Rene Leiva (MD CM, CCFP, FCFP) is a physican and researcher based in Ottawa, Ontario, Canada. Dr. Rene Leiva obtained his medical degree from McGill University, and is an Assistant Professor with the University of Ottawa, Department of Family Medicine. One of his main focuses of interests is modern methods of Fertility Awareness Methods and their impact on family planning and infertility. He has published several peer-reviewed research articles.